RT Book, Section A1 Phillips, Margaret A. A1 Stanley, Samuel L. A2 Brunton, Laurence L. A2 Chabner, Bruce A. A2 Knollmann, Björn C. SR Print(0) ID 1127870390 T1 Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 12e YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071624428 LK accessmedicine.mhmedical.com/content.aspx?aid=1127870390 RD 2023/09/27 AB Humans host a wide variety of protozoal parasites that can be transmitted by insect vectors, directly from other mammalian reservoirs or from one person to another. Because protozoa multiply rapidly in their hosts and effective vaccines are unavailable, chemotherapy has been the only practical way to both treat infected individuals and reduce transmission. The immune system plays a crucial role in protecting against the pathological consequences of protozoal infections. Thus, opportunistic infections with protozoa are prominent in infants, individuals with cancer, transplant recipients, those receiving immunosuppressive drugs or extensive antibiotic therapy, and persons with advanced human immunodeficiency virus (HIV) infection. Treatment of protozoal infections in immunocompromised individuals is especially difficult, and the outcome is often unsatisfactory.